MEMBER OF THE BOARD OF DIRECTORS, Chairman AND CHIEF EXECUTIVE OFFICER/MR. ÉTIENNE FRECHIN’S SON

First appointed to the Board of Directors
Annual General Meeting of May 22, 2006 as a director

Expiry of term of office
Annual General Meeting to be held in 2026 to approve the financial statements for the year ending December 31, 2025

Career
• Chief Operating Officer appointed by the Board of Directors, August 21, 2006
• Chief Executive Officer appointed by the Board of Directors, December 10, 2009, effective April 1, 2010
• Chairman and CEO appointed by the Board of Directors, May 25, 2023, effective July 1, 2023

Training
• Doctor of Pharmacy, University of Nancy, 1995
• Postgraduate doctoral degree (DEA) in industrial systems engineering

Current terms of office held in French and foreign companies
• Member of the Soparfin SCA Supervisory Board, Vetoquinol SA holding company
• Chairman of Lustah SAS
• Chairman or director of certain Vetoquinol Group unlisted subsidiaries
• Chief Executive Officer of Demabel SAS